Home Blog Page 4

Short QT Syndrome Genetic Test: Heart Rhythm Genes and Results

Understand how short QT syndrome genetic testing evaluates heart rhythm genes, why ECG context and gene validity matter, and what positive, uncertain, or negative results mean.

Short QT syndrome is a very rare inherited electrical disorder in which the heart’s recovery time between beats is abnormally brief, creating vulnerability to...

Thoracic Aortic Aneurysm Genetic Test: FBN1, TGFBR1, TGFBR2, and Results

Learn how thoracic aortic aneurysm genetic testing evaluates FBN1, TGFBR1, TGFBR2, and other HTAD genes and how results guide imaging, surgery, and family care.

A thoracic aortic aneurysm develops when part of the aorta within the chest enlarges and its wall becomes vulnerable to tearing or rupture. Genetic...

Thrombophilia Genetic Test: Factor V Leiden, Prothrombin G20210A, and Results

Learn when thrombophilia genetic testing for factor V Leiden and prothrombin G20210A is useful, how other clotting tests differ, and what results mean for care.

A thrombophilia genetic test looks for inherited changes that increase susceptibility to venous blood clots, most commonly factor V Leiden in F5 and prothrombin...

Vascular Ehlers-Danlos Syndrome Genetic Test: COL3A1 Gene and Results

Learn how COL3A1 genetic testing confirms vascular Ehlers-Danlos syndrome, how variant types affect interpretation, and how results guide surveillance, emergencies, and family care.

Vascular Ehlers-Danlos syndrome, or vEDS, is a rare inherited connective-tissue disorder marked by fragility of arteries, bowel, uterus, skin, and other tissues. A clinical-grade...

Wilson Disease Genetic Test: ATP7B, Copper Metabolism, and Results

Learn how ATP7B genetic testing fits into Wilson disease diagnosis, how copper tests and variant results are interpreted, and how treatment and family screening prevent injury.

Wilson disease is a treatable inherited disorder in which impaired ATP7B function prevents normal handling and biliary excretion of copper. Copper first accumulates in...

ALK Mutation Test: Lung Cancer, Targeted Therapy, and Results

Understand what an ALK mutation test detects in lung cancer, how tissue and liquid biopsy results are interpreted, and how ALK-positive findings guide targeted therapy.

An ALK mutation test looks for an abnormal change involving the ALK gene in cancer cells. In lung cancer, the important finding is usually...

APC Genetic Test: Familial Adenomatous Polyposis, Colon Cancer Risk, and Results

Learn what an APC genetic test can show, how positive, negative, and uncertain results are interpreted, and how FAP findings guide colon surveillance, surgery, and family testing.

An APC genetic test looks for inherited harmful variants in the APC gene, the main cause of familial adenomatous polyposis. Familial adenomatous polyposis, or...

ASXL1 Mutation Test: Blood Cancer, Myeloid Neoplasm, and Results

Understand what an ASXL1 mutation test shows in blood and bone marrow, how results relate to myeloid neoplasms and clonal hematopoiesis, and how they affect prognosis and follow-up.

An ASXL1 mutation test looks for acquired changes in the ASXL1 gene in blood or bone marrow cells. ASXL1 variants are found in several...

ATM Genetic Test: Breast Cancer Risk, DNA Repair, and Results

Learn what an ATM genetic test shows, how positive, negative, and uncertain results affect breast and other cancer risk, and how screening and family testing are planned.

An ATM genetic test looks for an inherited harmful variant in the ATM gene, which helps cells recognize and repair damaged DNA. People with...

BAP1 Genetic Test: Melanoma, Mesothelioma, Kidney Cancer Risk, and Results

Learn what a BAP1 genetic test shows, how results relate to melanoma, mesothelioma, and kidney cancer risk, and how surveillance and family testing are planned.

A BAP1 genetic test looks for an inherited harmful variant in the BAP1 gene, which can cause BAP1 tumor predisposition syndrome. This rare syndrome...

BCL2 Rearrangement Test: Follicular Lymphoma, Double-Hit Lymphoma, and Results

Understand what a BCL2 rearrangement test shows, how results support follicular lymphoma diagnosis, and why concurrent MYC and BCL2 rearrangements identify double-hit lymphoma.

A BCL2 rearrangement test looks for a chromosome change that places the BCL2 gene under the control of a highly active partner, most often...

BCL6 Rearrangement Test: Lymphoma, Prognosis, and Results

Learn what a BCL6 rearrangement test shows, how positive and negative results are interpreted, and how BCL6, MYC, and BCL2 findings affect lymphoma classification and prognosis.

A BCL6 rearrangement test looks for a structural change involving the BCL6 gene on chromosome 3. BCL6 normally helps germinal-center B cells grow, change...

BCR-ABL1 Test: CML, Leukemia, Philadelphia Chromosome, and Results

Understand BCR-ABL1 testing for CML and Philadelphia-positive leukemia, including diagnostic methods, International Scale results, molecular response milestones, and resistance testing.

A BCR-ABL1 test detects or measures the fusion gene that drives chronic myeloid leukemia and a major subtype of acute lymphoblastic leukemia. The fusion...

BRAF Mutation Test: Melanoma, Colon, Thyroid, Lung Cancer, and Results

Understand BRAF mutation testing in melanoma, colorectal, thyroid, and lung cancer, including V600E results, testing methods, targeted therapy, and negative-test limitations.

A BRAF mutation test looks for changes in the BRAF gene, which controls part of the MAPK signaling pathway that tells cells when to...

BRCA1 and BRCA2 Genetic Test: Cancer Risk, Mutations, and Results

Understand BRCA1 and BRCA2 genetic testing, cancer risks, positive, negative, and VUS results, screening, preventive surgery, treatment options, and family testing.

A BRCA1 and BRCA2 genetic test looks for inherited or tumor-acquired changes in two genes that repair damaged DNA. A germline pathogenic variant can...

CALR Mutation Test: Myeloproliferative Neoplasm, Platelets, and Results

Understand CALR mutation testing for high platelets, essential thrombocythemia, and primary myelofibrosis, including type 1 and type 2 results, prognosis, and follow-up.

A CALR mutation test looks for acquired changes in the calreticulin gene, usually small insertions or deletions in exon 9. These mutations are major...

CCND1/IGH Fusion Test: Mantle Cell Lymphoma and Results

Understand the CCND1/IGH fusion test for mantle cell lymphoma, including t(11;14), FISH results, cyclin D1 and SOX11 findings, prognosis, and diagnostic limits.

A CCND1/IGH fusion test looks for the chromosome translocation t(11;14)(q13;q32), which places CCND1 next to the immunoglobulin heavy-chain gene IGH. The change causes excess...

CDH1 Genetic Test: Hereditary Diffuse Gastric Cancer Risk and Results

Understand CDH1 genetic testing, diffuse gastric and lobular breast cancer risks, positive and VUS results, expert endoscopy, preventive gastrectomy, and family testing.

A CDH1 genetic test looks for inherited changes in the gene that makes E-cadherin, a protein that helps epithelial cells attach to one another....

CEBPA Mutation Test: AML Prognosis, Leukemia Genetics, and Results

Understand CEBPA mutation testing in AML, including in-frame bZIP results, favorable-risk classification, germline familial leukemia, treatment, MRD, and test limitations.

A CEBPA mutation test looks for changes in a gene that controls the maturation of myeloid blood cells. CEBPA mutations occur in a subset...

CHEK2 Genetic Test: Breast, Colon, Prostate Cancer Risk, and Results

Understand CHEK2 genetic test results, variant-specific breast cancer risk, changing colon guidance, prostate screening, inheritance, family testing, and next steps.

A CHEK2 genetic test looks for inherited changes in a DNA-damage response gene associated most consistently with a moderate increase in female breast cancer...